Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01485861
What this trial is testing

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Who this might be right for
Prostate Cancer
Genentech, Inc. 298
Testing effectiveness (Phase 2)Ended earlyNCT01866423
What this trial is testing

Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Southern California 4
Large-scale testing (Phase 3)Study completedNCT01605227
What this trial is testing

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Who this might be right for
Prostate CancerCastration Resistant Prostate CancerPain+1 more
Exelixis 1,028
Testing effectiveness (Phase 2)Looking for participantsNCT07192120
What this trial is testing

MHB048C in Patients With Advanced Solid Tumors

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd 200
Not applicableUnknownNCT02362620
What this trial is testing

PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.

Who this might be right for
Advanced Prostate CancerCabazitaxelDocetaxel
Centro Nacional de Investigaciones Oncologicas CARLOS III 402
Not applicableStudy completedNCT04232761
What this trial is testing

Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone

Who this might be right for
Castration-resistant Prostate Cancer
Bayer 194
Testing effectiveness (Phase 2)Looking for participantsNCT04986423
What this trial is testing

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 200
Early research (Phase 1)Study completedNCT01351688
What this trial is testing

An Open Label Prostate Cancer Study in Japanese Patients

Who this might be right for
Prostate Cancer
AstraZeneca 13
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Very early researchStudy completedNCT02415621
What this trial is testing

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 19
Large-scale testing (Phase 3)Study completedNCT01193244
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,560
Testing effectiveness (Phase 2)Looking for participantsNCT05521412
What this trial is testing

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Peter MacCallum Cancer Centre, Australia 66
Early research (Phase 1)Active Not RecruitingNCT05806814
What this trial is testing

Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
University of Oklahoma 15
Not applicableStudy completedNCT02981797
What this trial is testing

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Who this might be right for
Prostate CancerProstate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableLooking for participantsNCT06529549
What this trial is testing

Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT04408924
What this trial is testing

Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Eli Lilly and Company 44
Testing effectiveness (Phase 2)Study completedNCT05549778
What this trial is testing

Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Jiangnan University 12
Not applicableStudy completedNCT05362149
What this trial is testing

An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings

Who this might be right for
Non-metastatic Castration-resistant Prostate Cancer
Bayer 870
Large-scale testing (Phase 3)Ended earlyNCT04844749
What this trial is testing

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

Who this might be right for
Metastatic Castration-resistant Prostate CancerAndrogen Resistant Prostatic Cancer
Veru Inc. 105
Next Page